Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | AMPH | TSHA | ||
| Company | Supernus Pharm | Amphastar Pharma | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.35 | 41.15 | 2.41 | ||
| High | 30.73 | 41.87 | 2.48 | ||
| Low | 30.35 | 41.15 | 2.39 | ||
| Last | 30.51 | 41.46 | 2.48 | ||
| Change | +0.44 | +0.35 | +0.09 | ||
| % Change | +1.46% | +0.85% | +3.77% | ||
| Volume | 6,230 | 33,885 | 163,008 | ||
| 20-Day Average Volume | 333,030 | 315,440 | 1,699,354 | ||
| Previous Close | 30.07 | 41.11 | 2.39 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 30.89 | 40.77 | 2.63 | ||
| 20-Day Raw Stochastic | 35.84% | 68.96% | 22.71% | ||
| 20-Day Relative Strength | 49.13% | 43.91% | 47.75% | ||
| Weighted Alpha | -9.44 | -3.85 | +9.58 | ||
| Today's Opinion | 40% Buy | 88% Sell | 48% Buy | ||
| Previous Opinion | 40% Buy | 88% Sell | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.43% since 04/22/24 | +3.77% since 04/22/24 | -1.22% since 04/22/24 | ||
| Low | 29.17 on 04/26/24 | 40.29 on 04/23/24 | 2.16 on 04/25/24 | ||
| High | 31.84 on 04/23/24 | 41.87 on 04/29/24 | 2.61 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -9.91% since 03/28/24 | -5.07% since 03/28/24 | -15.33% since 03/28/24 | ||
| Low | 28.63 on 04/18/24 | 38.43 on 04/18/24 | 2.14 on 04/19/24 | ||
| High | 34.49 on 04/04/24 | 43.97 on 04/01/24 | 3.40 on 04/10/24 | ||
| 3-Month | |||||
| %Chg | +5.71% since 01/29/24 | -24.74% since 01/29/24 | +51.88% since 01/29/24 | ||
| Low | 26.27 on 02/28/24 | 38.43 on 04/18/24 | 1.41 on 02/14/24 | ||
| High | 35.44 on 03/21/24 | 56.45 on 02/12/24 | 3.55 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | +30.43% since 10/27/23 | -6.62% since 10/27/23 | +9.71% since 10/27/23 | ||
| Low | 23.05 on 11/07/23 | 38.43 on 04/18/24 | 1.27 on 11/14/23 | ||
| High | 35.44 on 03/21/24 | 65.92 on 01/05/24 | 3.55 on 03/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,645,881 | 2,008,881 | 446,973 | ||
| Shares Outstanding, K | 54,735 | 48,866 | 187,018 | ||
| Annual Sales | 607,520,000 | 644,400,000 | 15,450,000 | ||
| Annual Net Income | 1,320,000 | 137,550,000 | -111,570,000 | ||
| Last Quarter Sales | 164,310,000 | 178,110,000 | 3,600,000 | ||
| Last Quarter Net Income | 1,170,000 | 36,170,000 | 47,740,000 | ||
| 60-Month Beta | 0.99 | 0.84 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.02 on 02/27/24 | 0.88 on 02/28/24 | 0.35 on 03/19/24 | ||
| Latest Earnings Date | 05/08/24 | 05/14/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.66 | 0.00 | ||